Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olodaterol 24-hour FEV1 Profile in Asthma
NCT01311661Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Started Mar 2011; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01311661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01311661.